Boston Scientific Corp Stock Performance
| BSX Stock | USD 77.64 2.14 2.83% |
The firm shows a Beta (market volatility) of -0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Boston Scientific are expected to decrease at a much lower rate. During the bear market, Boston Scientific is likely to outperform the market. At this point, Boston Scientific Corp has a negative expected return of -0.4%. Please make sure to confirm Boston Scientific's jensen alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if Boston Scientific Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Boston Scientific Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 2.83 | Five Day Return (16.56) | Year To Date Return (18.02) | Ten Year Return 367.15 | All Time Return 1.7 K |
Last Split Factor 2:1 | Last Split Date 2003-11-06 |
1 | BlackRock earnings, Spotify to raise premium price in the US | 01/15/2026 |
2 | Will Robust MedSurg Performance Fuel Boston Scientifics Q4 Earnings | 01/28/2026 |
3 | Boston Scientific Stock Analyst Estimates Ratings | 01/29/2026 |
4 | Boston Scientific Garnering Bullish Views Amid Penumbra Acquisition | 01/30/2026 |
5 | Principal Financial Group Inc. Sells 215,555 Shares of Boston Scientific Corporation BSX | 02/02/2026 |
6 | Boston Scientific Q4 2025 Earnings Preview | 02/03/2026 |
7 | Stock Market Today, Feb. 4 Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors | 02/04/2026 |
| Begin Period Cash Flow | 1.1 B | |
| Total Cashflows From Investing Activities | -5.7 B |
Boston Scientific Relative Risk vs. Return Landscape
If you would invest 10,091 in Boston Scientific Corp on November 8, 2025 and sell it today you would lose (2,327) from holding Boston Scientific Corp or give up 23.06% of portfolio value over 90 days. Boston Scientific Corp is generating negative expected returns assuming volatility of 2.7155% on return distribution over 90 days investment horizon. In other words, 24% of stocks are less volatile than Boston, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Boston Scientific Target Price Odds to finish over Current Price
The tendency of Boston Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 77.64 | 90 days | 77.64 | close to 99 |
Based on a normal probability distribution, the odds of Boston Scientific to move above the current price in 90 days from now is close to 99 (This Boston Scientific Corp probability density function shows the probability of Boston Stock to fall within a particular range of prices over 90 days) .
Boston Scientific Price Density |
| Price |
Predictive Modules for Boston Scientific
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Boston Scientific Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Boston Scientific's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Boston Scientific Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Boston Scientific is not an exception. The market had few large corrections towards the Boston Scientific's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Boston Scientific Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Boston Scientific within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 5.00 | |
Ir | Information ratio | -0.15 |
Boston Scientific Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Boston Scientific for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Boston Scientific Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Boston Scientific generated a negative expected return over the last 90 days | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from fool.com: Stock Market Today, Feb. 4 Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors |
Boston Scientific Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Boston Stock often depends not only on the future outlook of the current and potential Boston Scientific's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Boston Scientific's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 B | |
| Cash And Short Term Investments | 414 M |
Boston Scientific Fundamentals Growth
Boston Stock prices reflect investors' perceptions of the future prospects and financial health of Boston Scientific, and Boston Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Boston Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0576 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 122.74 B | ||||
| Shares Outstanding | 1.48 B | ||||
| Price To Earning | 107.05 X | ||||
| Price To Book | 4.79 X | ||||
| Price To Sales | 5.74 X | ||||
| Revenue | 20.07 B | ||||
| Gross Profit | 13.81 B | ||||
| EBITDA | 5.31 B | ||||
| Net Income | 1.85 B | ||||
| Cash And Equivalents | 414 M | ||||
| Cash Per Share | 0.24 X | ||||
| Total Debt | 11.15 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | 15.78 X | ||||
| Cash Flow From Operations | 3.44 B | ||||
| Earnings Per Share | 2.00 X | ||||
| Market Capitalization | 115.14 B | ||||
| Total Asset | 39.4 B | ||||
| Retained Earnings | 2.67 B | ||||
| Working Capital | 521 M | ||||
| Current Asset | 1.21 B | ||||
| Current Liabilities | 923 M | ||||
About Boston Scientific Performance
Evaluating Boston Scientific's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Boston Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Boston Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 182.02 | 153.65 | |
| Return On Tangible Assets | 0.12 | 0.14 | |
| Return On Capital Employed | 0.09 | 0.18 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.10 | 0.06 |
Things to note about Boston Scientific Corp performance evaluation
Checking the ongoing alerts about Boston Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Boston Scientific Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Boston Scientific generated a negative expected return over the last 90 days | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from fool.com: Stock Market Today, Feb. 4 Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors |
- Analyzing Boston Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Boston Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Boston Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Boston Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Boston Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Boston Scientific's stock. These opinions can provide insight into Boston Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.